Advertisement

Topics

Wellspring Biosciences, Janssen Receive IND Clearance

04:55 EDT 17 May 2019 | Contract Pharma

Janssen Biotech will conduct the Phase I trial for ARS-3248, a small molecule KRAS G12C inhibitor

Original Article: Wellspring Biosciences, Janssen Receive IND Clearance

NEXT ARTICLE

More From BioPortfolio on "Wellspring Biosciences, Janssen Receive IND Clearance"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...